More News
2 January 2020
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets2 January 2020
Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson2 January 2020
Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China30 December 2019
Milestone for Biopharmaceuticals in China30 December 2019
Acceleron and Fulcrum Therapeutics Announce Pulmonary Research and Discovery Collaboration Agreement27 December 2019
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.23 December 2019
Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program23 December 2019
Bausch Health Licenses Novaliq’s NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction21 December 2019
Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer20 December 2019
GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia20 December 2019
AskBio Licenses Rights to Selecta Biosciences’ ImmTOR™ Immune Tolerance Platform for the Treatment of Pompe Disease20 December 2019
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics20 December 2019
PharmaMar and Jazz Pharmaceuticals Sign Exclusive License Agreement for Lurbinectedin in the U.S.20 December 2019
Rheos Medicines Announces Worldwide Collaboration with Roche to Discover and Develop Novel Medicines in the Field of Immunometabolism19 December 2019
Turnstone Biologics Announces Global Collaboration and License Agreement with Takeda to Develop Novel Viral Immunotherapies19 December 2019
Oxurion NV to Focus Clinical Development on Molecules Targeting VEGF Independent Pathways for Treatment of DME19 December 2019
Ionis licenses investigational Alzheimer’s therapyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports